Medibank FY26: The Good, the Bad and the Ugly for Dividend Investors
Medibank’s FY26 headline profit jumped 27.5% and its fully franked dividend increased 6.7%, but underlying earnings tell a more modest story.
Medibank’s FY26 headline profit jumped 27.5% and its fully franked dividend increased 6.7%, but underlying earnings tell a more modest story.
A bigger dividend cheque does not always mean your income is really growing. Here is a simple way to test whether your portfolio’s cash flow is keeping pace with inflation, and which income sources can help over the long run.
Private credit can provide attractive monthly income, but the distribution rate does not tell the full story. Here are eight checks Australian income investors can use to assess loan quality, valuations, liquidity, fees and portfolio concentration.
Cash Converters offers a fully franked yield above 6%, but the income case depends on dividend cover, credit quality, acquisitions and the FY2026 result.
BKI’s FY26 result was not spectacular, but it was useful for income investors: fully franked dividends, a 4%+ cash yield, low costs, no debt and quarterly payments from FY27.
GCI’s June update strengthens the monthly income case, but rising borrower dispersion means credit risk still deserves close monitoring.
WHI’s June quarter shows attractive fully franked monthly income, but the premium to NTA means valuation discipline still matters.
My FY26 portfolio produced record income, but listed credit fund capital weakness showed why yield still needs risk discipline and better diversification.
Plenti’s FY26 annual report shows strong cash-profit growth and disciplined credit metrics, but it remains a future dividend candidate rather than an income stock today.
My portfolio value rose 3% since April as capital gains joined dividends in driving returns, while credit funds remained the main area to watch.